GoAI
Get started
ASKA Pharmaceutical Holdings Co.,Ltd. logo

ASKA Pharmaceutical Holdings Co.,Ltd.

4886.T

JPXHealthcareDrug Manufacturers - Specialty & Generic

Open in GoAI

Latest quote

¥2,159

−¥11.00 · -0.51%

Aug 24, 11:30 AM JST

4886.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

ASKA Pharmaceutical Holdings Co.,Ltd. is a Japanese enterprise that operates through its subsidiaries in three primary areas: pharmaceuticals, animal healthcare, and hormone testing services. The company's pharmaceutical division is dedicated to the research, development, production, and commercialization of medications, with a specific focus on endocrinology, obstetrics and gynecology, and urology. Within its animal health segment, ASKA manufactures, sells, imports, and exports a broad spectrum of veterinary products, such as medicines, medical equipment, animal feed and supplements, laboratory reagents, agricultural chemicals, industrial chemicals, hygiene products, and food items along with their raw materials. Beyond these activities, the company also performs clinical and biological testing and offers medical devices. Founded in 1920, ASKA Pharmaceutical Holdings Co.,Ltd. is headquartered in Tokyo, Japan.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Headquarters
JP
CEO
Takashi Yamaguchi
Listed since
Apr 1, 2021
Employees
1,611

Market position

Day range

Current ¥2,159

52-week range

Current ¥2,159

Open
¥2,187
Previous close
¥2,170
Volume
25.7K
0.25× average
Average volume
104.7K
Average daily volume
Market cap
61.31B JPY
Beta
0.45
Market reference 1
50-day average
¥2,231.7
-3.26% below average
200-day average
¥2,349.96
-8.13% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
68.29B JPY
P/E (TTM)
13.01×
P/B (TTM)
0.87×
P/S (TTM)
0.87×
EV / EBITDA
7.66×
Earnings yield
8.10%
Free cash flow yield
5.60%
Dividend yield
2.78%

Profitability & efficiency

Gross margin
47.42%
Operating margin
7.15%
Net margin
6.65%
Return on equity
7.75%
Return on assets
4.84%
Return on invested capital
5.05%

Financial health

Debt / equity
0.17×
Current ratio
2.76×
Altman Z-score
3.14
Piotroski F-score
4 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends53%36%20%3%Gross margin, FY2021: 46.55%Gross margin, FY2022: 47.28%Gross margin, FY2023: 48.80%Gross margin, FY2024: 48.86%Gross margin, FY2025: 48.01%Operating margin, FY2021: 8.47%Operating margin, FY2022: 8.45%Operating margin, FY2023: 10.34%Operating margin, FY2024: 8.31%Operating margin, FY2025: 8.20%Net margin, FY2021: 7.58%Net margin, FY2022: 7.01%Net margin, FY2023: 12.01%Net margin, FY2024: 7.95%Net margin, FY2025: 7.63%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 46.55%. Gross margin FY2022 47.28%. Gross margin FY2023 48.80%. Gross margin FY2024 48.86%. Gross margin FY2025 48.01%. Operating margin FY2021 8.47%. Operating margin FY2022 8.45%. Operating margin FY2023 10.34%. Operating margin FY2024 8.31%. Operating margin FY2025 8.20%. Net margin FY2021 7.58%. Net margin FY2022 7.01%. Net margin FY2023 12.01%. Net margin FY2024 7.95%. Net margin FY2025 7.63%.

Income trends

Revenue

71.13B JPY+10.90%

Operating income

5.83B JPY+9.39%

Net income

5.43B JPY+6.35%
Income trends across reported periods77.82B JPY51.06B JPY24.3B JPY−2.45B JPYRevenue, FY2021: 56.61B JPYRevenue, FY2022: 60.46B JPYRevenue, FY2023: 62.84B JPYRevenue, FY2024: 64.14B JPYRevenue, FY2025: 71.13B JPYOperating income, FY2021: 4.8B JPYOperating income, FY2022: 5.11B JPYOperating income, FY2023: 6.5B JPYOperating income, FY2024: 5.33B JPYOperating income, FY2025: 5.83B JPYNet income, FY2021: 4.29B JPYNet income, FY2022: 4.24B JPYNet income, FY2023: 7.55B JPYNet income, FY2024: 5.1B JPYNet income, FY2025: 5.43B JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 56.61B JPY. Revenue FY2022 60.46B JPY. Revenue FY2023 62.84B JPY. Revenue FY2024 64.14B JPY. Revenue FY2025 71.13B JPY. Operating income FY2021 4.8B JPY. Operating income FY2022 5.11B JPY. Operating income FY2023 6.5B JPY. Operating income FY2024 5.33B JPY. Operating income FY2025 5.83B JPY. Net income FY2021 4.29B JPY. Net income FY2022 4.24B JPY. Net income FY2023 7.55B JPY. Net income FY2024 5.1B JPY. Net income FY2025 5.43B JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue71.13B JPY64.14B JPY62.84B JPY60.46B JPY56.61B JPY
Cost of goods sold36.98B JPY32.8B JPY32.18B JPY31.88B JPY30.26B JPY
Gross profit34.15B JPY31.34B JPY30.67B JPY28.59B JPY26.35B JPY
Research and development7.06B JPY7.03B JPY4.73B JPY4.23B JPY3.6B JPY
Selling, general, and administrative21.25B JPY18.97B JPY19.44B JPY19.25B JPY17.96B JPY
Operating expenses28.31B JPY26B JPY24.16B JPY23.48B JPY21.56B JPY
Interest income—6M JPY4M JPY——
Interest expense222M JPY51M JPY40M JPY50M JPY56M JPY
Depreciation and amortization3.09B JPY2.25B JPY2.66B JPY3.13B JPY2.89B JPY
Operating income5.83B JPY5.33B JPY6.5B JPY5.11B JPY4.8B JPY
Net income5.43B JPY5.1B JPY7.55B JPY4.24B JPY4.29B JPY

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
100%
1 beat, 0 misses, 0 met estimates
Average EPS surprise
+2.60%
1 comparable report
Latest EPS result
18.77

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates62.3346.8731.4115.95Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 5, 2024: actual 45.41, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 3, 2025: actual 54.23, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 12, 2025: actual 35.36, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 4, 2025: actual 43.88, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 4, 2025: actual 34.61, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 2, 2026: actual 59.1, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 11, 2026: actual 53.53, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 4, 2026: actual 18.77, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates20.09B17.88B15.66B13.44BQ1 '25BeatQ2 '25MissQ3 '25MetQ4 '25MissQ1 '26No estimateQ2 '26No estimateQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 3, 2025: actual 17.56B JPY, estimate 17.54B JPY, surprise +0.09%, Beat. Q2 2025, reported May 12, 2025: actual 14.21B JPY, estimate 14.51B JPY, surprise -2.05%, Miss. Q3 2025, reported Aug 4, 2025: actual 19.32B JPY, estimate 19.32B JPY, surprise 0.00%, Met estimate. Q4 2025, reported Nov 4, 2025: actual 15.93B JPY, estimate 17.61B JPY, surprise -9.54%, Miss. Q1 2026, reported Feb 2, 2026: actual 19.23B JPY, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 11, 2026: actual 16.64B JPY, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 4, 2026: actual 17.38B JPY, estimate 17.7B JPY, surprise -1.79%, Miss. Q4 2026, reported Nov 9, 2026: actual —, estimate 17.64B JPY, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

¥57.00

2025 complete year+307.1% since 2021

2026 partial: ¥33.00

* Partial calendar year in the available dividend history.

Corporate action history

DividendUpcoming

Ex-dividend Sep 29, 2026

¥32.00

Semi-Annual

Record Sep 30, 2026 · Payment Sep 29, 2026

DividendUpcoming

Ex-dividend Mar 30, 2027

¥33.00

Semi-Annual

Record Mar 31, 2027 · Payment Mar 30, 2027

Dividend

Ex-dividend Mar 30, 2026

¥33.00

Semi-Annual

Record Mar 31, 2026 · Payment Jun 25, 2026

Dividend

Ex-dividend Sep 29, 2025

¥27.00

Semi-Annual

Record Sep 30, 2025 · Payment Nov 28, 2025

Dividend

Ex-dividend Mar 28, 2025

¥30.00

Semi-Annual

Record Mar 31, 2025 · Payment Jun 25, 2025

Dividend

Ex-dividend Sep 27, 2024

¥25.00

Semi-Annual

Record Sep 30, 2024 · Payment Nov 29, 2024

4886.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥7,008

-0.04%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,799

+0.61%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,990

+0.38%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,205

+0.08%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,862

+1.01%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,392.5

+0.23%

ETFs holding 4886.T

Funds reporting this stock among their holdings, ordered by reported position size.

iShares Core TOPIX ETF logoiShares Core TOPIX ETF1475.T
Market value
105.68M
Weight
0.00%
AUM
2.89T JPY
Expense ratio
0.05%
Price / 1D
¥418.5+0.12%
Vanguard Total International Stock ETF logoVanguard Total International Stock ETFVXUS
Market value
3.7M
Weight
0.00%
AUM
646.2B USD
Expense ratio
0.05%
Price / 1D
$87.71+0.78%
Vanguard FTSE Developed Markets ETF logoVanguard FTSE Developed Markets ETFVEA
Market value
2.82M
Weight
0.00%
AUM
315B USD
Expense ratio
0.03%
Price / 1D
$73.42+0.80%
Avantis International Small Cap Value ETF logoAvantis International Small Cap Value ETFAVDV
Market value
1.25M
Weight
0.01%
AUM
20.24B USD
Expense ratio
0.36%
Price / 1D
$111.95+1.06%
Vanguard FTSE All-World ex-US Small-Cap ETF logoVanguard FTSE All-World ex-US Small-Cap ETFVSS
Market value
1.02M
Weight
0.01%
AUM
13.6B USD
Expense ratio
0.06%
Price / 1D
$160.06+0.43%
Schwab International Small-Cap Equity ETF logoSchwab International Small-Cap Equity ETFSCHC
Market value
593.71K
Weight
0.01%
AUM
5.73B USD
Expense ratio
0.06%
Price / 1D
$51.25+0.61%
Dimensional - International Small Cap Value ETF logoDimensional - International Small Cap Value ETFDISV
Market value
561.24K
Weight
0.01%
AUM
5.23B USD
Expense ratio
0.42%
Price / 1D
$44.49+0.86%
Dimensional - International Small Cap ETF logoDimensional - International Small Cap ETFDFIS
Market value
439.17K
Weight
0.01%
AUM
5.91B USD
Expense ratio
0.39%
Price / 1D
$37.545+0.71%

Continue in GoAI

Research 4886.T

research.disclaimer